Résultats de la recherche

  • Flux RSS
(1 - 20 of 29)

Pages

Translational approach and models to assess the anticancer activity of organomatallic drugs
Cancer Cell Cytotoxicity of Cyclometalated Compounds Obtained with Osmium(II) Complexes
Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates
Targeting redox enzymes of the endoplasmic reticulum with organometallic compounds: treats and tricks leading to cancer cell death
Novel Flavaglines Displaying Improved Cytotoxicity
Regulation of p73 expression and activity upon DNA damage in neurons and cancers cells from the nervous system
Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: Passing the nanomolar barrier
Characterisation of the anticancer-activity of novel omium cytotoxic compounds
Identification et caractérisation de molécules anticancéreuses à base de ruthénium
Sensibilisation de lignées tumorales des voies aérodigestives supérieures à la radiothérapie par le ciblage thérapeutique de l'axe EGFR / mTOR / HIF-1
Role of the p53 family in cachexia
Discovery and Investigation of Anticancer Ruthenium-Arene Schiff-Base Complexes via Water-Promoted Combinatorial Three-Component Assembly
Redox role of organometallic compounds in their biological activity
Regulation of HDAC4 by mir140 and the p53 family in gastric cancer
Identification of cytotoxic drugs displaying p53-independent activity
Design of Porphyrin-dota-Like Scaffolds as All-in-One Multimodal Heterometallic Complexes for Medical Imaging
Regulation of a Notch3-Hes1 Pathway and Protective Effect by a Tocopherol-Omega Alkanol Chain Derivative in Muscle Atrophy
Gold-phosphine-porphyrin as potential metal-based theranostics
Role of p53 family in muscular atrophy
Role of p53 family in muscular atrophy

Pages

Islandora displays